Subclinical leaflet thrombosis after transcatheter aortic valve replacement and anticoagulant treatment: lights and shadows Francesco CondelloMatteo SturlaRiccardo Terzi Letter to the Editor 23 September 2021 Pages: 561 - 563
Time to consider neuroinflammation as a booster effect of cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia? Benjamin MarchandotAdrien CarmonaOlivier Morel Letter to the Editor 09 November 2021 Pages: 564 - 566
COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation Mohamad RaadSarah GorgisSachin Parikh OriginalPaper 23 September 2021 Pages: 567 - 575
Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation Giuseppe Di TanoMeghi DedeGian Battista Danzi Report 27 October 2021 Pages: 576 - 580
The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury Giuseppe LippiIvan SzergyukBrandon Michael Henry BriefCommunication 28 October 2021 Pages: 581 - 585
A comprehensive review of vascular complications in COVID-19 Yogesh AcharyaAqeel AlameerSherif Sultan ReviewPaper 01 November 2021 Pages: 586 - 593
Efficacy and safety of rivaroxaban in cerebral venous thrombosis: insights from a prospective cohort study Liqun PanMengqi WangRan Meng OriginalPaper 03 November 2021 Pages: 594 - 600
Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series Deborah DeCamilloBrian HaymartGeoffrey D. Barnes OriginalPaper 24 September 2021 Pages: 601 - 606
Direct oral anticoagulants for secondary stroke prevention in patients over 80 years of age: the role of geriatric functional status Senta FrolLiam Korošec HudnikJanja Pretnar Oblak OriginalPaper 16 October 2021 Pages: 607 - 615
The safety and efficacy of systemic versus catheter-based therapies: application of a prognostic model by a pulmonary embolism response team Jean-Pierre IskandarEssa HaririScott J. Cameron OriginalPaper 29 September 2021 Pages: 616 - 625
Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic Michelle PapalaDeborah GillardLisa E. Rein OriginalPaper 08 October 2021 Pages: 626 - 632
Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation Chun-Li WangVictor Chien-Chia WuShang-Hung Chang OriginalPaper 23 September 2021 Pages: 633 - 645
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study Bingwen Eugene FanKollengode RamanathanYew Woon Chia OriginalPaper 28 September 2021 Pages: 646 - 662
Non-contrast-enhanced magnetic resonance imaging technique diagnoses DVT and classifies thrombus Shanshan ShenYanqin LanYingmin Chen OriginalPaper 10 August 2021 Pages: 663 - 670
Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients Bryan ChongRachel Sze Jen GohPoay Huan Loh OriginalPaper 04 January 2022 Pages: 671 - 682
Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall Chukwuemeka A. ObiKishen BulsaraEun Ji Kim OriginalPaper 04 September 2021 Pages: 683 - 689
Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism Vickie KwanEric KaplovitchJameel Abdulrehman BriefCommunication 06 October 2021 Pages: 690 - 696
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves Arjun K. PandeyKe XuRichard P. Whitlock OriginalPaper 08 October 2021 Pages: 697 - 707
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia Abraham Z. CheloffAndrew B. SongHanny Al-Samkari BriefCommunication 25 October 2021 Pages: 708 - 711
Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality Patrick Malcolm SiegelJulia ChalupskyPhilipp Diehl OriginalPaper Open access 16 September 2021 Pages: 712 - 721
Outcomes and risk factors of perforating and non-perforating middle cerebral artery infarctions after intravenous thrombolysis Hongyu WeiYiqing WangZenglin Cai OriginalPaper 14 January 2022 Pages: 722 - 730
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study Syed Nabeel MuzaffarSuhail Sarwar SiddiquiAfzal Azim Letter to the Editor 20 November 2021 Pages: 731 - 733
Delayed diagnosis of congenital thrombotic thrombocytopenic purpura in a patient with recurrent strokes Marina Beltrami-MoreiraMaria T. DeSancho Report 12 January 2022 Pages: 734 - 738
Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes Plinio CirilloStefano ConteGiovanni Cimmino OriginalPaper 20 October 2021 Pages: 739 - 749
Endothelial progenitor cells overexpressing platelet derived growth factor-D facilitate deep vein thrombosis resolution Haolong ZhangHailong LuoJianming Sun OriginalPaper 20 October 2021 Pages: 750 - 760